These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7522466)

  • 1. CD28-B7 interactions in T-cell activation.
    Allison JP
    Curr Opin Immunol; 1994 Jun; 6(3):414-9. PubMed ID: 7522466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
    Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
    Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell co-stimulation and in vivo tolerance.
    Lenschow DJ; Bluestone JA
    Curr Opin Immunol; 1993 Oct; 5(5):747-52. PubMed ID: 7694594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
    Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
    Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
    Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands.
    Murtaza A; Kuchroo VK; Freeman GJ
    Int Immunol; 1999 Mar; 11(3):407-16. PubMed ID: 10221652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
    García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
    Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
    Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
    Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
    Hathcock KS; Laszlo G; Pucillo C; Linsley P; Hodes RJ
    J Exp Med; 1994 Aug; 180(2):631-40. PubMed ID: 7519245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection.
    Cook CH; Chen L; Wen J; Zimmerman P; Zhang Y; Trgovcich J; Liu Y; Gao JX
    Viral Immunol; 2009 Apr; 22(2):91-103. PubMed ID: 19326996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell co-signalling molecules in graft-versus-host disease.
    Tanaka J; Asaka M; Imamura M
    Ann Hematol; 2000 Jun; 79(6):283-90. PubMed ID: 10901605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes.
    Scottà C; Soligo M; Camperio C; Piccolella E
    J Immunol; 2008 Jul; 181(2):1025-33. PubMed ID: 18606654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early T cell receptor signals globally modulate ligand:receptor affinities during antigen discrimination.
    Pielak RM; O'Donoghue GP; Lin JJ; Alfieri KN; Fay NC; Low-Nam ST; Groves JT
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):12190-12195. PubMed ID: 29087297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
    Fallarino F; Fields PE; Gajewski TF
    J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.
    Ndejembi MP; Teijaro JR; Patke DS; Bingaman AW; Chandok MR; Azimzadeh A; Nadler SG; Farber DL
    J Immunol; 2006 Dec; 177(11):7698-706. PubMed ID: 17114440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mast cells costimulate T cells through a CD28-independent interaction.
    Suurmond J; Dorjée AL; Huizinga TW; Toes RE
    Eur J Immunol; 2016 May; 46(5):1132-41. PubMed ID: 26860071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
    Nieland JD; Kruisbeek AM
    Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro.
    Levine BL; Ueda Y; Craighead N; Huang ML; June CH
    Int Immunol; 1995 Jun; 7(6):891-904. PubMed ID: 7577797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28-B7-2 but not CD28-B7-1 interaction is required for T cell costimulation in experimental obliterative bronchiolitis in the rat.
    Tikkanen JM; Lemström KB; Koskinen PK
    Transplant Proc; 2001; 33(1-2):535. PubMed ID: 11266944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.